{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:31:52Z","timestamp":1783488712969,"version":"3.55.0"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,12,24]],"date-time":"2021-12-24T00:00:00Z","timestamp":1640304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p><jats:bold>Introduction:<\/jats:bold> This cardiovascular magnetic resonance (CMR) study aims to determine whether changes in systemic vascular resistance (SVR), obtained from CMR flow sequences, might explain the significant long-term changes in left ventricular (LV) ejection fraction (EF) observed in subjects with no cardiac disease history.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Cohort subjects without any known cardiac disease but with high rates of hypertension and obesity, underwent CMR with phase-contrast sequences both at baseline and at a median follow-up of 5.2 years. Longitudinal changes in EF were analyzed for any concomitant changes in blood pressure and vascular function, notably the indexed SVR given by the formula: mean brachial blood pressure \/ cardiac output x body surface area.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> A total of 118 subjects (53 \u00b1 12 years, 52% women) were included, 26% had hypertension, and 52% were obese. Eighteen (15%) had significant EF variations between baseline and follow-up (7 increased EF and 11 decreased EF). Longitudinal changes in EF were inversely related to concomitant changes in mean and diastolic blood pressures (<jats:italic>p<\/jats:italic> = 0.030 and <jats:italic>p<\/jats:italic> = 0.027, respectively) and much more significantly to SVR (<jats:italic>p<\/jats:italic> &amp;lt; 0.001). On average, these SVR changes were \u22128.08 \u00b1 9.21 and +8.14 \u00b1 8.28 mmHg.min.m<jats:sup>2<\/jats:sup>.L<jats:sup>\u22121<\/jats:sup>, respectively, in subjects with significant increases and decreases in EF, and 3.32 \u00b1 7.53 mmHg.min.m<jats:sup>2<\/jats:sup>.L<jats:sup>\u22121<\/jats:sup> in subjects with a stable EF (overall <jats:italic>p<\/jats:italic> &amp;lt; 0.001).<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> Significant EF variations are not uncommon during the long-term CMR follow-up of populations with no evident health issues except for uncomplicated hypertension and obesity. However, most of these variations are linked to SVR changes and may therefore be unrelated to any intrinsic change in LV contractility. This underscores the benefits of specifically assessing LV afterload when EF is monitored in populations at risk of vascular dysfunction.<\/jats:p><jats:p><jats:bold>Clinical Trial Registration:<\/jats:bold><jats:ext-link>ClinicalTrials.gov<\/jats:ext-link>, identifier: NCT01716819 and NCT02430805.<\/jats:p>","DOI":"10.3389\/fcvm.2021.803567","type":"journal-article","created":{"date-parts":[[2021,12,24]],"date-time":"2021-12-24T07:24:35Z","timestamp":1640330675000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Relationship Between Left Ventricular Ejection Fraction Variation and Systemic Vascular Resistance: A Prospective Cardiovascular Magnetic Resonance Study"],"prefix":"10.3389","volume":"8","author":[{"given":"Damien","family":"Mandry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Girerd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohra","family":"Lamiral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Huttin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Filippetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilien","family":"Micard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Beaumont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Paule Bernadette","family":"Ncho Mottoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Pace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fa\u00efez","family":"Zannad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Rossignol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Yves","family":"Marie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,12,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.pcad.2020.05.007","article-title":"Quantifying left ventricular function in heart failure: what makes a clinically valuable parameter?","volume":"63","author":"Harbo","year":"2020","journal-title":"Prog Cardiovasc Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12872-017-0556-8","article-title":"The emerging role of cardiovascular magnetic resonance in the evaluation of hypertensive heart disease","volume":"17","author":"Mavrogeni","year":"2017","journal-title":"BMC Cardiovasc Disord."},{"key":"B3","doi-asserted-by":"publisher","first-page":"20140831","DOI":"10.1259\/bjr.20140831","article-title":"Variability in cardiac MR measurement of left ventricular ejection fraction, volumes and mass in healthy adults: defining a significant change at 1 year","volume":"88","author":"Moody","year":"2015","journal-title":"Br J Radiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1532-429X-15-51","article-title":"Guidelines and protocols for cardiovascular magnetic resonance in children and adults with congenital heart disease: SCMR expert consensus group on congenital heart disease","volume":"15","author":"Fratz","year":"2013","journal-title":"J Cardiovasc Magn Reson."},{"key":"B5","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jcmg.2018.10.007","article-title":"First-phase ejection fraction: the FEV1 of the heart?","volume":"12","author":"Dahl","year":"2019","journal-title":"JACC Cardiovasc Imaging."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e016009","DOI":"10.1161\/JAHA.119.016009","article-title":"Associations of left ventricular structure and function with blood pressure in heart failure with preserved ejection fraction: analysis of the TOPCAT trial","volume":"9","author":"Wei","year":"2020","journal-title":"J Am Heart Assoc."},{"key":"B7","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/S1071-3581(95)80025-5","article-title":"Abnormal left ventricular ejection fraction response to mental stress and exercise in cardiomyopathy","volume":"2","author":"Wolz","year":"1995","journal-title":"J Nucl Cardiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S0735-1097(10)80332-8","article-title":"Comparison of physiologic ejection fraction responses to activities of daily living: implications for clinical testing","volume":"16","author":"Bairey","year":"1990","journal-title":"J Am Coll Cardiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1093\/ehjci\/jex244","article-title":"Standardization of adult transthoracic echocardiography reporting in agreement with recent chamber quantification, diastolic function, and heart valve disease recommendations: an expert consensus document of the European Association of Cardiovascular Imaging","volume":"18","author":"Galderisi","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging."},{"key":"B10","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s00259-007-0694-9","article-title":"EANM\/ESC guidelines for radionuclide imaging of cardiac function","volume":"35","author":"Hesse","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B11","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1093\/ejechocard\/jer051","article-title":"Recommendations of the European Association of Echocardiography: how to use echo-Doppler in clinical trials: different modalities for different purposes","volume":"12","author":"Galderisi","year":"2011","journal-title":"Eur J Echocardiogr."},{"key":"B12","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1097\/HJH.0000000000000889","article-title":"Comprehensive monitoring of cardiac remodeling with aortic stroke volume values provided by a phase-contrast MRI sequence","volume":"34","author":"Marie","year":"2016","journal-title":"J Hypertens."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12968-016-0314-6","article-title":"Cardiac remodeling following reperfused acute myocardial infarction is linked to the concomitant evolution of vascular function as assessed by cardiovascular magnetic resonance","volume":"19","author":"Huttin","year":"2017","journal-title":"J Cardiovasc Magn Reson."},{"key":"B14","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1097\/HJH.0b013e32834f6f3f","article-title":"Comprehensive MRI analysis of early cardiac and vascular remodeling in middle-aged patients with abdominal obesity","volume":"30","author":"Mandry","year":"2012","journal-title":"J Hypertens."},{"key":"B15","doi-asserted-by":"publisher","first-page":"771022","DOI":"10.3389\/fcvm.2021.771022","article-title":"Arterial and cardiac remodeling associated with extra weight gain in an isolated abdominal obesity cohort","volume":"8","author":"Mandry","year":"2021","journal-title":"Front Cardiovasc Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.1748-1716.2006.01596.x","article-title":"Contribution of systemic arterial compliance and systemic vascular resistance to effective arterial elastance changes during exercise in humans","volume":"188","author":"Otsuki","year":"2006","journal-title":"Acta Physiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"R228","DOI":"10.1152\/ajpregu.00009.2008","article-title":"Systemic arterial compliance, systemic vascular resistance, and effective arterial elastance during exercise in endurance-trained men","volume":"295","author":"Otsuki","year":"2008","journal-title":"Am J Physiol Regul Integr Comp Physiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1007\/s00134-016-4212-z","article-title":"Understanding arterial load","volume":"42","author":"Monge Garc\u00eda","year":"2016","journal-title":"Intensive Care Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"H614","DOI":"10.1152\/ajpheart.00823.2002","article-title":"Contribution of systemic vascular resistance and total arterial compliance to effective arterial elastance in humans","volume":"285","author":"Chemla","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"16","DOI":"10.2174\/1573402113666170505115010","article-title":"Microvascular alterations in hypertension and vascular aging","volume":"13","author":"Savoia","year":"2017","journal-title":"Curr Hypertens Rev."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1093\/cvr\/cvx093","article-title":"The microcirculation: a key player in obesity-associated cardiovascular disease","volume":"113","author":"Sorop","year":"2017","journal-title":"Cardiovasc Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"662","DOI":"10.2214\/AJR.07.3744","article-title":"Cardiovascular applications of phase-contrast MRI","volume":"192","author":"Srichai","year":"2009","journal-title":"AJR Am J Roentgenol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1177\/0003319706294558","article-title":"Systemic peripheral vascular resistance as a determinant of functional cardiac reserve in response to exercise in patients with heart disease","volume":"58","author":"Akima","year":"2007","journal-title":"Angiology."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1586\/erc.12.108","article-title":"Reassessing the use of vasodilators in heart failure","volume":"10","author":"Cole","year":"2012","journal-title":"Expert Rev Cardiovasc Ther."},{"key":"B25","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/jmri.21401","article-title":"Comparison of the reproducibility of quantitative cardiac left ventricular assessments in healthy volunteers using different MRI scanners: a multicenter simulation","volume":"28","author":"Gandy","year":"2008","journal-title":"J Magn Reson Imaging."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.803567\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,24]],"date-time":"2021-12-24T07:24:37Z","timestamp":1640330677000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.803567\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,24]]},"references-count":25,"alternative-id":["10.3389\/fcvm.2021.803567"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2021.803567","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,24]]},"article-number":"803567"}}